Bruker Corporation (BRKR) 24.80 $BRKR
Short Interest In Bruker Expands By 15.4%
MarketNewsVideo.com - Fri Jun 10, 1:31PM CDT
The most recent short interest data has been released for the 05/31/2016 settlement date, which shows a 764,514 share increase in total short interest for Bruker Corp , to 5,717,406, an increase of 15.44% since 05/13/2016. Total short interest is...
BRKR: 24.80 (-0.81)
Bruker Shows Innovative rapifleX MALDI-TOF/TOF at ASMS 2016
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces rapifleX(TM), the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX is by far the most advanced TOF/TOF system today, and was re-designed from the ground up to meet today's highest demands for in-depth intact and top-down protein characterization, and high-performance, high-throughput mass spectrometry imaging (MSI).
BRKR: 24.80 (-0.81)
Bruker Launches rapifleX MALDI PharmaPulse Solution for uHTS
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX(TM) MALDI PharmaPulse(TM) (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
BRKR: 24.80 (-0.81)
Bruker Introduces Innovative timsTOF(TM) Mass Spectrometer
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF(TM) system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
BRKR: 24.80 (-0.81)
Why These Stocks are Under the Investor Community's Microscope? - Bruker, Quintiles Transnational Holdings, iKang Healthcare Group, and TrovaGene
PR Newswire - Wed Jun 01, 7:20AM CDT
In today's pre-market research, ActiveWallSt.com has selected the following Medical Laboratories and Research stocks for your evaluation: Bruker Corp. (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), iKang Healthcare Group Inc. (NASDAQ: KANG), and TrovaGene Inc. (NASDAQ: TROV). Access these equities free technical alerts at:
Q: 65.57 (-0.97), TROV: 4.28 (-0.60), KANG: 19.72 (+0.08), BRKR: 24.80 (-0.81)
Dr. Cynthia Friend Joins Bruker Board of Directors
PR Newswire - Mon May 23, 9:46AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its shareholders have elected Dr. Cynthia Friend as a new member of the Board of Directors, effective May 20, 2016.
BRKR: 24.80 (-0.81)
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:44AM CDT
Waters Corporation (WAT) expanded its portfolio of Xevo mass spectrometers with the launch of Xevo TQ-XS mass spectrometer, which is arguably the most sensitive instrument of its kind in the market.
BEAT: 16.69 (+0.15), BRKR: 24.80 (-0.81), PKI: 53.69 (-0.60), WAT: 138.04 (-2.01)
Bruker: Q1 Results Strong, Product Launches Hold Promise
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:02AM CDT
Bruker (BRKR) started 2016 on a promising note, with its first-quarter results beating the Zacks Consensus Estimate on both the fronts.
BSX: 23.02 (-0.30), SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), BRKR: 24.80 (-0.81)
Bruker Announces Quarterly Dividend
PR Newswire - Tue May 17, 6:33AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on June 24, 2016 to stockholders of record as of June 6, 2016.
BRKR: 24.80 (-0.81)
Bruker Introduces New High-Value Analytical Solutions and High Performance Scientific Instruments for Applied and Industrial Markets at Analytica 2016
PR Newswire - Tue May 10, 3:25AM CDT
This week at Analytica 2016, Bruker (NASDAQ: BRKR) is showcasing new products and analytical solutions for improved performance and customer experience in pharmaceutical, industrial and applied markets. Designed to increase sensitivity, improve specificity and maximize productivity, the new Bruker products introduced at Analytica 2016 include:
BRKR: 24.80 (-0.81)
PerkinElmer (PKI) Beats Q1 Earnings & Revenues, View Up
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:27AM CDT
PerkinElmer Inc (PKI) reported first-quarter 2016 earnings of 56 cents per share, which beat the Zacks Consensus Estimate by a nickel.
BRKR: 24.80 (-0.81), PKI: 53.69 (-0.60), WAT: 138.04 (-2.01), MTD: 377.69 (-7.81)
Downgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Fri May 06, 3:12AM CDT
Bruker (NASDAQ:BRKR) was downgraded from Buy to Neutral at BTIG today. The stock closed yesterday at $27.20 on volume of 1.9 million shares, above average daily volume of 1.1 million. Over the past year, Bruker has traded in a range of $15.78 to $29.85 and closed yesterday at $27.20, 72% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.7% while the 200-day MA has risen 0.6%.
BRKR: 24.80 (-0.81)
Bruker (BRKR) Tops Q1 Earnings & Revenues; Keeps '16 View
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:31AM CDT
Bruker (BRKR) has had a promising journey so far this year, with its first-quarter results beating the Zacks Consensus Estimate on both the fronts.
BSX: 23.02 (-0.30), SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), BRKR: 24.80 (-0.81)
Bruker beats Street 1Q forecasts
Automated Insights - Wed May 04, 4:03PM CDT
BILLERICA, Mass. (AP) _ Bruker Corp. (BRKR) on Wednesday reported first-quarter net income of $23.6 million.
BRKR: 24.80 (-0.81)
Bruker Reports First Quarter 2016 Financial Results
PR Newswire - Wed May 04, 3:01PM CDT
Bruker Corporation (NASDAQ: BRKR) today reported financial results for its first quarter ended March 31, 2016.
BRKR: 24.80 (-0.81)
Waters Corp. (WAT) Q1 Earnings Top on Operational Strength
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 9:06AM CDT
Waters Corporation (WAT) reported first-quarter 2016 adjusted earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.23 by 2.4% and the prior-year quarter figure of $1.21 per share by 4.1%.
BRKR: 24.80 (-0.81), MTSC: 42.68 (-0.18), WAT: 138.04 (-2.01), MTD: 377.69 (-7.81)
Bruker Announces Date and Time of First Quarter 2016 Earnings Release and Webcast
PR Newswire - Wed Apr 20, 12:00PM CDT
Bruker (NASDAQ: BRKR) today announced that it will disclose its first quarter 2016 financial results on Wednesday, May 4th, 2016, after the market close. The Company will then host a conference call and webcast at 4:45 p.m. Eastern Time to discuss the results and current business trends.
BRKR: 24.80 (-0.81)
Uptrend Call Working As Bruker Stock Rises 19.5% (BRKR)
Comtex SmarTrend(R) - Tue Apr 19, 1:24PM CDT
SmarTrend identified an Uptrend for Bruker (NASDAQ:BRKR) on February 11th, 2016 at $23.86. In approximately 2 months, Bruker has returned 19.46% as of today's recent price of $28.50.
BRKR: 24.80 (-0.81)
Bruker Up 21.3% Since SmarTrend Uptrend Call (BRKR)
Comtex SmarTrend(R) - Tue Apr 12, 12:25AM CDT
SmarTrend identified an Uptrend for Bruker (NASDAQ:BRKR) on February 11th, 2016 at $23.86. In approximately 2 months, Bruker has returned 21.32% as of today's recent price of $28.94.
BRKR: 24.80 (-0.81)
Bruker Introduces Important MALDI Biotyper Enhancements at ECCMID 2016: New Disposable MBT Biotargets 96, MBT Subtyping and Carbapenem Resistance Tests
PR Newswire - Mon Apr 11, 6:05AM CDT
At the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Bruker (Nasdaq: BRKR) introduces enhancements to the MALDI Biotyper (MBT) routine microbial identification workflow, and high-value expansions of the MBT assay menu to strain subtyping and to antimicrobial resistance testing for clinical and microbiology research:
BRKR: 24.80 (-0.81)
Short Interest In Bruker Expands By 15.4%
MarketNewsVideo.com - Fri Jun 10, 1:31PM CDT
The most recent short interest data has been released for the 05/31/2016 settlement date, which shows a 764,514 share increase in total short interest for Bruker Corp , to 5,717,406, an increase of 15.44% since 05/13/2016. Total short interest is...
BRKR: 24.80 (-0.81)
Bruker Shows Innovative rapifleX MALDI-TOF/TOF at ASMS 2016
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces rapifleX(TM), the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX is by far the most advanced TOF/TOF system today, and was re-designed from the ground up to meet today's highest demands for in-depth intact and top-down protein characterization, and high-performance, high-throughput mass spectrometry imaging (MSI).
BRKR: 24.80 (-0.81)
Bruker Launches rapifleX MALDI PharmaPulse Solution for uHTS
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX(TM) MALDI PharmaPulse(TM) (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
BRKR: 24.80 (-0.81)
Bruker Introduces Innovative timsTOF(TM) Mass Spectrometer
PR Newswire - Mon Jun 06, 6:00AM CDT
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF(TM) system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
BRKR: 24.80 (-0.81)
Why These Stocks are Under the Investor Community's Microscope? - Bruker, Quintiles Transnational Holdings, iKang Healthcare Group, and TrovaGene
PR Newswire - Wed Jun 01, 7:20AM CDT
In today's pre-market research, ActiveWallSt.com has selected the following Medical Laboratories and Research stocks for your evaluation: Bruker Corp. (NASDAQ: BRKR), Quintiles Transnational Holdings Inc. (NYSE: Q), iKang Healthcare Group Inc. (NASDAQ: KANG), and TrovaGene Inc. (NASDAQ: TROV). Access these equities free technical alerts at:
Q: 65.57 (-0.97), TROV: 4.28 (-0.60), KANG: 19.72 (+0.08), BRKR: 24.80 (-0.81)
Dr. Cynthia Friend Joins Bruker Board of Directors
PR Newswire - Mon May 23, 9:46AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its shareholders have elected Dr. Cynthia Friend as a new member of the Board of Directors, effective May 20, 2016.
BRKR: 24.80 (-0.81)
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:44AM CDT
Waters Corporation (WAT) expanded its portfolio of Xevo mass spectrometers with the launch of Xevo TQ-XS mass spectrometer, which is arguably the most sensitive instrument of its kind in the market.
BEAT: 16.69 (+0.15), BRKR: 24.80 (-0.81), PKI: 53.69 (-0.60), WAT: 138.04 (-2.01)
Bruker: Q1 Results Strong, Product Launches Hold Promise
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:02AM CDT
Bruker (BRKR) started 2016 on a promising note, with its first-quarter results beating the Zacks Consensus Estimate on both the fronts.
BSX: 23.02 (-0.30), SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), BRKR: 24.80 (-0.81)
Bruker Announces Quarterly Dividend
PR Newswire - Tue May 17, 6:33AM CDT
Bruker Corporation (NASDAQ: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock. The dividend will be paid on June 24, 2016 to stockholders of record as of June 6, 2016.
BRKR: 24.80 (-0.81)
Bruker Introduces New High-Value Analytical Solutions and High Performance Scientific Instruments for Applied and Industrial Markets at Analytica 2016
PR Newswire - Tue May 10, 3:25AM CDT
This week at Analytica 2016, Bruker (NASDAQ: BRKR) is showcasing new products and analytical solutions for improved performance and customer experience in pharmaceutical, industrial and applied markets. Designed to increase sensitivity, improve specificity and maximize productivity, the new Bruker products introduced at Analytica 2016 include:
BRKR: 24.80 (-0.81)
PerkinElmer (PKI) Beats Q1 Earnings & Revenues, View Up
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:27AM CDT
PerkinElmer Inc (PKI) reported first-quarter 2016 earnings of 56 cents per share, which beat the Zacks Consensus Estimate by a nickel.
BRKR: 24.80 (-0.81), PKI: 53.69 (-0.60), WAT: 138.04 (-2.01), MTD: 377.69 (-7.81)
Downgrade Alert for Bruker (BRKR)
Comtex SmarTrend(R) - Fri May 06, 3:12AM CDT
Bruker (NASDAQ:BRKR) was downgraded from Buy to Neutral at BTIG today. The stock closed yesterday at $27.20 on volume of 1.9 million shares, above average daily volume of 1.1 million. Over the past year, Bruker has traded in a range of $15.78 to $29.85 and closed yesterday at $27.20, 72% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.7% while the 200-day MA has risen 0.6%.
BRKR: 24.80 (-0.81)
Bruker (BRKR) Tops Q1 Earnings & Revenues; Keeps '16 View
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:31AM CDT
Bruker (BRKR) has had a promising journey so far this year, with its first-quarter results beating the Zacks Consensus Estimate on both the fronts.
BSX: 23.02 (-0.30), SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), BRKR: 24.80 (-0.81)
Bruker beats Street 1Q forecasts
Automated Insights - Wed May 04, 4:03PM CDT
BILLERICA, Mass. (AP) _ Bruker Corp. (BRKR) on Wednesday reported first-quarter net income of $23.6 million.
BRKR: 24.80 (-0.81)
Bruker Reports First Quarter 2016 Financial Results
PR Newswire - Wed May 04, 3:01PM CDT
Bruker Corporation (NASDAQ: BRKR) today reported financial results for its first quarter ended March 31, 2016.
BRKR: 24.80 (-0.81)
Waters Corp. (WAT) Q1 Earnings Top on Operational Strength
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 9:06AM CDT
Waters Corporation (WAT) reported first-quarter 2016 adjusted earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.23 by 2.4% and the prior-year quarter figure of $1.21 per share by 4.1%.
BRKR: 24.80 (-0.81), MTSC: 42.68 (-0.18), WAT: 138.04 (-2.01), MTD: 377.69 (-7.81)
Bruker Announces Date and Time of First Quarter 2016 Earnings Release and Webcast
PR Newswire - Wed Apr 20, 12:00PM CDT
Bruker (NASDAQ: BRKR) today announced that it will disclose its first quarter 2016 financial results on Wednesday, May 4th, 2016, after the market close. The Company will then host a conference call and webcast at 4:45 p.m. Eastern Time to discuss the results and current business trends.
BRKR: 24.80 (-0.81)
Uptrend Call Working As Bruker Stock Rises 19.5% (BRKR)
Comtex SmarTrend(R) - Tue Apr 19, 1:24PM CDT
SmarTrend identified an Uptrend for Bruker (NASDAQ:BRKR) on February 11th, 2016 at $23.86. In approximately 2 months, Bruker has returned 19.46% as of today's recent price of $28.50.
BRKR: 24.80 (-0.81)
Bruker Up 21.3% Since SmarTrend Uptrend Call (BRKR)
Comtex SmarTrend(R) - Tue Apr 12, 12:25AM CDT
SmarTrend identified an Uptrend for Bruker (NASDAQ:BRKR) on February 11th, 2016 at $23.86. In approximately 2 months, Bruker has returned 21.32% as of today's recent price of $28.94.
BRKR: 24.80 (-0.81)
Bruker Introduces Important MALDI Biotyper Enhancements at ECCMID 2016: New Disposable MBT Biotargets 96, MBT Subtyping and Carbapenem Resistance Tests
PR Newswire - Mon Apr 11, 6:05AM CDT
At the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Bruker (Nasdaq: BRKR) introduces enhancements to the MALDI Biotyper (MBT) routine microbial identification workflow, and high-value expansions of the MBT assay menu to strain subtyping and to antimicrobial resistance testing for clinical and microbiology research:
BRKR: 24.80 (-0.81)
